欧林生物: insider trades · France · AMF SSE:688319 FR FR · AMF Mcap 10.3Bn€
Discover the full directors' dealings record of 欧林生物, a publicly traded company based in France. Shares trade on FR FR, under the authority of AMF. Market capitalisation: €10.3bn. The latest transaction was reported on 12 May 2026 — Sale. Among the most active insiders: 陈克平. All data is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 704.2 M€
Gross profit 654.6 M€ 93% margin
Net income 22.3 M€ 3.2% margin
Balance sheet & cash
Market cap 10.29 Bn€
Total debt 433.0 M€
Free Cash Flow 6.7 M€
Last declaration on 12 May 2026
Declarations 10 total
Executives ● Sale3 SSE
2,000 shares
SSE:273000000606044160 · 12 May 2026
Executives ● Sale3 SSE
20,000 shares
SSE:273000000582980600 · 6 May 2026
Executives ● Purchase3 SSE
12,000 shares
SSE:273000000166046880 · 30 Jan 2026
Ideal exit: 27 Oct 2026 (T+270) Executives ● Sale3 SSE
10,000 shares
SSE:273000000105369800 · 9 Jan 2026
Executives ● Sale12 SSE
49,300 shares
SSE:173000009638679550 · 15 Oct 2025
Executives ● Sale3 SSE
10,000 shares
SSE:173000009272404860 · 23 Jul 2025
Executives ● Sale3 SSE
2,000 shares
SSE:173000009263032540 · 22 Jul 2025
Executives ● Sale3 SSE
60,000 shares
SSE:173000008830319650 · 21 Apr 2025
Executives ● Sale3 SSE
2,000 shares
SSE:173000007572414880 · 26 Apr 2024
Executives ● Sale3 SSE
9,934 shares
SSE:173000007054153280 · 1 Nov 2023